ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,171Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 288

$761K Total Retail Price of All Prescriptions

Rank: 14 out of 288

706 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 706 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 706 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 17,767 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 1,203 1,160 1 1
OMEPRAZOLE 897 805 2 3
LEVOTHYROXINE SODIUM 685 616 3 2
AMLODIPINE BESYLATE 612 596 4 6
METOPROLOL TARTRATE 514 498 5 8
METOPROLOL SUCCINATE 508 478 6 15
WARFARIN SODIUM 505 478 7 9
ATORVASTATIN CALCIUM 449 406 8 14
HYDROCHLOROTHIAZIDE 332 312 9 13
METFORMIN HCL 331 306 10 12
BUMETANIDE 327 310 11 105
CITALOPRAM HBR 325 316 12 18
HYDROCODONE-ACETAMINOPHEN 313 265 S3 13 7
ALENDRONATE SODIUM 308 283 14 20
POTASSIUM CHLORIDE 304 274 15 11
ENALAPRIL MALEATE 299 298 16 40
LOSARTAN POTASSIUM 276 267 17 16
ATENOLOL 265 260 18 10
MELOXICAM 253 243 19 44
TRAMADOL HCL 248 229 20 19
ALLOPURINOL 232 225 21 23
LISINOPRIL 214 207 22 4
POLYETHYLENE GLYCOL 3350 212 190 23 38
DIOVAN 188 185 24 53
PREDNISONE 187 181 25 30
ROPINIROLE HCL 178 166 26 74
CARBIDOPA-LEVODOPA 177 176 27 72
GLIMEPIRIDE 170 162 28 32
LOSARTAN-HYDROCHLOROTHIAZIDE 158 154 29 55
GABAPENTIN 157 148 30 17
ENALAPRIL-HYDROCHLOROTHIAZIDE 155 149 31 192
FUROSEMIDE 151 131 32 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 124 33 34
ISOSORBIDE MONONITRATE ER 140 140 34 35
GLYBURIDE 131 112 R 35 59
TAMSULOSIN HCL 125 102 36 24
SERTRALINE HCL 122 98 37 25
TRIAMTERENE-HYDROCHLOROTHIAZID 119 118 38 142
PAROXETINE HCL 112 101 39 54
DILTIAZEM 24HR CD 108 104 40 75
DONEPEZIL HCL 108 105 40 29
PRAVASTATIN SODIUM 107 107 42 21
NEXIUM 104 80 43 43
CLOPIDOGREL 97 92 44 47
DIGOXIN 96 94 45 51
FENTANYL 93 91 S2 46 57
CIPROFLOXACIN HCL 92 81 47 62
INDAPAMIDE 92 92 47 244
PLAVIX 89 84 49 71
RANITIDINE HCL 87 84 50 33
PROPRANOLOL HCL 85 84 51 90
CRESTOR 85 77 51 26
CARVEDILOL 84 84 53 27
ADVAIR DISKUS 82 70 54 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 74 55 113
FLUTICASONE PROPIONATE 80 67 56 41
AMLODIPINE BESYLATE-BENAZEPRIL 79 65 57 89
TRIAMCINOLONE ACETONIDE 78 77 58 139
VERAPAMIL ER 75 75 59 97
EVISTA 74 69 60 126
BENAZEPRIL HCL 72 60 61 52
LANTUS 72 58 61 31
VENLAFAXINE HCL ER 71 71 63 94
ZOLPIDEM TARTRATE 68 66 64 22
CELEBREX 68 68 64 84
FLUOXETINE HCL 65 61 66 64
MIRTAZAPINE 64 64 67 60
AZITHROMYCIN 64 58 67 49
TRIAMTERENE-HCTZ 64 58 67 28
NAMENDA 63 52 70 39
CYMBALTA 63 63 70 67
FINASTERIDE 62 62 72 82
DIOVAN HCT 61 51 73 112
CLONIDINE HCL 58 46 74 70
GLIPIZIDE 55 55 75 56
DOXAZOSIN MESYLATE 54 53 76 78
ALBUTEROL SULFATE 54 32 76 133
ZETIA 54 54 76 58
KLOR-CON 10 53 40 79 66
SINGULAIR 53 30 79 86
DETROL LA 51 51 81 162
TRAZODONE HCL 51 34 81 37
PREMARIN 51 46 R 81 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.